Mathew T H, Fazzalari R A, Disney A P, MacIntyre D B
Nephron. 1981;27(4-5):222-5. doi: 10.1159/000182058.
Multiple uses of dialyzers has been studied in a single hospital and by survey of all Australian dialysis units. An annual saving of $84,000 was achieved in a 46-patient unit. No significant patient morbidity or mortality occurred. In Australia 43% of all haemodialysis patients are on a multiple use regime. The 1-year patient cumulative survival for units with a reuse policy is 92.8% and for those with a single use of policy is 87.1%. Anti-N-like antibodies are being found in low but increasing frequency as the reuse program continues.
一家医院以及通过对澳大利亚所有透析单位的调查,对透析器的多次使用进行了研究。在一个有46名患者的单位实现了每年84,000美元的节省。未发生显著的患者发病或死亡情况。在澳大利亚,所有血液透析患者中有43%采用多次使用方案。采用复用政策的单位患者1年累计生存率为92.8%,采用单次使用政策的单位为87.1%。随着复用计划的持续进行,发现抗N样抗体的频率较低但在增加。